unexpected increases in demand — e.g. “Elevata richiesta” (Italy)
manufacturing problems — e.g. “Problemi produttivi” (Italy)
supply-chain disruption — e.g. “Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.” (Spain)
causes not stated by the regulator — e.g. “Motivi commerciali” (Italy)
Recent shortage history
Italy: resolved 8 Nov 2025 (began 8 Nov 2025)
Italy: resolved 31 Jan 2023 (began 31 Jan 2023)
Italy: resolved 28 Feb 2022 (began 28 Feb 2022)
Italy: resolved 1 Aug 2019 (began 1 Aug 2019)
Italy: resolved 8 Mar 2018 (began 8 Mar 2018)
Italy: resolved 1 Jan 2018 (began 1 Jan 2018)
Frequently asked questions
Is Voriconazolo currently in shortage?
Yes. As of the latest regulator updates, Voriconazolo has 8 active shortage notices across 2 countries (Italy, Spain). Status is refreshed daily from official regulatory sources.
Why is Voriconazolo in shortage?
Regulators attribute the current Voriconazolo shortages to unexpected increases in demand, manufacturing problems, supply-chain disruption. The exact cause varies by country and product — each notice on this page links to the official source.
When will the Voriconazolo shortage be resolved?
Regulator-estimated resolution dates currently range from 30 Sept 2026 to 28 Feb 2027, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Where does this Voriconazolo shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Get alerted when Voriconazolo status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Data on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.